Keenova Announces Newly Updated Peyronie's Disease Study Results at American Urology Association Meeting

DUBLIN, May 15, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that new and final updated data from its dedicated ventral curvature analysis of Peyronie's disease and XIAFLEX® (collagenase clostridium histolyticum) will be shared at the American Urological Association (AUA)...

Read More